Advertisement

Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81
Financing › Details

Abcam–SEVERAL: investment, 202010 US IPO $156.5m+23.5m with 8.95m+1.34m ADSs at $17.5/ADS at Nasdaq Global Market

 

Period Period 2020-10-19 ï¿½ 2020-10-23
Region Region United States (USA)
Organisations Money taker Abcam plc (AIM: ABC, Nasdaq: ABCM)
  Group Abcam (Group)
  Money source SEVERAL
Products Product research antibody
  Product 2 investment banking
Document Source Abcam plc. (10/23/20). "Press Release: Abcam Announces Exercise of Over-allotment Option [not for any jurisdiction where a violation of relevant laws]". London.
     

   
Record changed: 2020-10-23

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

More documents for Abcam (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80




» top